brain

Combating Counterfeit Drugs

By: Azia Tariq, Staff Editor - With the sale of counterfeit drugs reaching an alarmingly higher rate than ever, The…

12 years ago

The Surgeon General’s 2014 Report on Smoking

By: Ada Seldin, Staff Editor - Since the first release of the Surgeon General’s Report on smoking 50 years ago,…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

The Status of Surveillance of Japanese Encephalitis in Asia

By: Sabrina Ahmed, PharmD Candidate c/o 2017 - One recent stride towards combating worldwide infectious disease has been in the…

12 years ago

A Walk To Remember

By: Caitie Stehling, PharmD Candidate c/o 2015 - St. John’s University is grounded in its Catholic, Vincentian, and Metropolitan mission.…

12 years ago

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

BRAIN Initiative: Mapping the Human Brain

By Erica Dimitropoulos, Senior Staff Editor - If you were in charge of government spending, how would you allocate our…

13 years ago

New Findings Regarding Cardiovascular Adverse Events with ADHD Medications

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] - Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns…

13 years ago

Drugs and Diseases: The Survival Manual

By: Beatrisa Popovitz, Staff Editor -  You may have heard the countless horror stories passed on by upperclassman of how…

13 years ago

Alzheimer’s Disease On The Rise

By: Ada Seldin - An impending storm is threatening to stagger the health care system and the nation at large.…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

The Role of NMDA in Electroconvulsive Therapy and Other Neuropsychological Disorders

By: Neal Shah, Co-Editor-in-Chief - Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other…

14 years ago

Use of Donepezil in Patients with Delirium (but without Dementia)

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Donepezil, brand name Aricept®, is an acetylcholinesterase inhibitor indicated as monotherapy…

14 years ago

The Pathophysiology of Syndeham’s Chorea

By: Neal Shah, Co Editor-In-Chief - Dyskinesias are abnormal, involuntary movement disorders.  Subsets of dyskinesias include choreas and atheosis.  Chorea…

14 years ago

Impact of Gender and Race on the Efficacy on Opiods

By: Lunbao (Jerry) Huang, Pharm.D.  Candidate c/o 2013 - Pain is a very difficult condition to manage, as clinicians have…

14 years ago

The End of an Era

By: Pooja Patel, Pharm.D. Candidate c/o 2013 - The ‘end of an era’ is a fitting way to describe my…

14 years ago

Reflection on my 4th Year of Pharmacy

By: SlanixPaul T.  Alex, Pharm.D. Candidate c/o 2014 - Progressing into one’s fourth year of college is usually a time…

14 years ago

Sativex®: A Realistic Option for Advanced Cancer Pain?

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 - Nabiximols (Sativex®) is a buccal spray that has been approved for use…

14 years ago

Clevidipine in the Management of Hypertensive Emergency

By: Neal Shah - Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than…

14 years ago

Differences Between Antagonists and Inverse Agonists

By: Neal Shah - There are two major classifications of drug-receptor activity: agonism and antagonism. Agonism occurs when a molecule…

15 years ago

Ivabradine: A Novel I(f) Blocker for Stable Angina

By: Neal Shah - Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel…

15 years ago